Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAVENUE THERAPEUTICS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

AVENUE THERAPEUTICS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jan 2, 2026Fortress Biotech, Inc.10% Owner111,209COMMON STOCK, PAR VALUE $0.0001—Grant / award
Mar 31, 2025Fortress Biotech, Inc.10% Owner33,724COMMON STOCK, PAR VALUE $0.0001—Grant / award
Dec 2, 2024Herskowitz NeilDirector23COMMON STOCK, PAR VALUE $0.0001—Sell
Nov 5, 2024KRANZLER JAY DDirector61COMMON STOCK, PAR VALUE $0.0001—Sell
Sep 30, 2024KRANZLER JAY DDirector497COMMON STOCK, PAR VALUE $0.0001—Buy
Sep 27, 2024KRANZLER JAY DDirector3COMMON STOCK, PAR VALUE $0.0001—Buy
Sep 23, 2024Charles Faith L.Director30,000Employee stock option (right to buy)—Grant / award
Sep 23, 2024Jin DavidInterim PFO and COO65,000COMMON STOCK, PAR VALUE $0.0001—Grant / award
Sep 23, 2024KRANZLER JAY DDirector30,000Employee stock option (right to buy)—Grant / award
Sep 23, 2024MacLean AlexandraChief Executive Officer170,000COMMON STOCK, PAR VALUE $0.0001—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$0.38Close · Oct 7, 2026